Becker ENT & Allergy opens a third Voorhees location to streamline specialty care and meet growing demand for ENT and allergy ...

With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS ...

DUBAI, AE / ACCESS Newswire / May 5, 2025 / Recovery these days in the fast-paced world is not only about rest but innovation ...

MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025.Financial Results and Recent ...

Poll of 273 Healthcare Leaders Uncovers Escalating Challenges in Prior Authorization, Data Exchange, and Value-Based Contracting. NEW YORK CITY, NEW YORK / ACCESS Newswire / May 5, 2025 / A new survey ...

MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its second quarter dividend of $0.90 per common share on August 1, 2025, ...

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / May 5, 2025 / Genomate Health, a precision oncology company developing a new category of computational tools for Digital Drug Assignment (DDA) - a method ...

In its Report, Egan Jones concludes: "…NHI has taken substantial steps to address governance concerns on the board, especially with regards to the NHC lease negotiation. In our view, many of ...

Tesela Copilot Accelerates R&D, Fully Embedded in TeselaGen's Cutting-Edge ELN and Platform PORTOLA VALLEY, CALIFORNIA / ACCESS Newswire / May 5, 2025 / TeselaGen, a leading provider of AI-augmented ...

KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to ...

Appointment brings public policy expertise, strategic insight, and business development acumen as AIML accelerates global AI healthcare deployment. VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / ...

LUND, SE / ACCESS Newswire / May 5, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...